With new therapies that promise to slow Alzheimer’s disease ... - CNN
WEBJul 16, 2023 — Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
Researchers have found a protein that seems to protect brain cells …
WEBJul 24, 2024 — A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
Alzheimer's News -- ScienceDaily
WEB3 days ago — Learn about Alzheimer's Disease symptoms such as memory loss and senile dementia. Find out about the treatments and causes, as well as the stages of Alzheimer's Disease and dementia.
Second Alzheimer’s drug to slow disease’s progression may be ... - CNN
WEBJul 17, 2023 — The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been...
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 — CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing...
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 — A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds - The New York Times. It was much more accurate than primary care doctors using cognitive tests and CT...
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 — PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 — The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 — The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
Study finds no uniform brain shrinkage pattern in Alzheimer's
WEB1 day ago — Published in Alzheimer's & Dementia, the study is the first to compare individual patterns of brain shrinkage over time in people with mild memory problems or Alzheimer's disease against a healthy ...